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Table 1. BMTOrientation Pathways
Type of RN
Length
of Orientation
Number
of Orientees
Track 1 Novice
(New RN or Nurse\2 years)
15 - 24 weeks 15
Track 2 Advanced Beginner
(Nurse with experience
in Med-Surg, Heme/Onc,
or Critical Care)
7 - 14 weeks 22
Track 3 Expert (Nurse with
BMTexperience)
4 - 6 weeks 4
S320 Poster Session IIPurpose: Processes and peer data are available to address patient
satisfaction in the inpatient setting, but evaluating satisfaction in
the outpatient setting has been historically over-looked. Our
outpatient apheresis unit has established a mechanism to assess
patient satisfaction and address the unobserved needs of our
patients.
Methods: We have developed patient satisfaction cards that are
given to patients upon completion of their procedure. Patients
have the opportunity to rate their care by answering the following
questions:
Was the procedure thoroughly explained by the apheresis staff?
Were your needs met during the procedure?
Were you treated in a courteous and professional manner?
Can you please rate the overall apheresis experience?
Ratings are on a scale from 1 to 5 with 1 being ‘very poor’ to 5 be-
ing ‘very good’. Patients are also given the opportunity to provide
comments regarding their procedure and the entire apheresis pro-
cess. The self-addressed scorecards are sent directly to our program’s
quality management coordinator for review and evaluation. Survey
participants are anonymous with names being optional.
Results:The goal of our hospital is to have a ‘good’ or ‘very good’
response on 90% of all patient satisfaction surveys. Our goal is to
exceed the needs of each patient and stay in-line with the hospital’s
desired goal. Tabulated results are reviewed with the apheresis
staff and are presented quarterly at our transplant program’s qual-
ity management meetings. Results and comments are posted
within the apheresis unit for continuous visualization of patient
satisfaction. Comments for improvement are entered into our
unit’s complaint log and are reviewed during our department
meetings.
Conclusion: Improved patient satisfaction is a high priority at our
institution. Patient satisfaction assessment is an excellent mechanism
for quality improvement activities. Evaluation of care, planning for
improvement and documentation of actions taken are a required
quality improvement activities for FACT accreditation for our
blood and marrow collection facility. Comment cards give our
patients an opportunity to express their appreciation for the care
provided by our staff. This provides an excellent affirmation of
a job well done.444
GROWTH OF A BMT UNIT IN TOUGH ECONOMIC TIMES: SUCCESS WITH A
STRUCTURED PROGRAM AND INNOVATIVE SOURCES OF FUNDING
Beaupierre, A.1, Thirlwell, S.1, Gillespie, M.1, Jones, G.M.2,
Reardon, M.B.1 1Moffitt Cancer Center, Tampa, FL; 2Moffitt Cancer
Center, Tampa, FL
In the past year, the Blood and Marrow Transplant (BMT) pro-
gram at our NCI-designated Cancer Center increased its inpatient
bed capacity by 80% and additional nursing staff was needed.
Given the challenges of the nursing shortage, the present economic
climate and the reality that nurses with BMT experience are un-
common, the Director of BMT and Critical Care Nursing, the
BMT Clinical Nurse Specialist (CNS) and the BMT Patient
Care Manager (PCM) formulated a plan to recruit and orient
nurses to meet our increased need and sought novel ways to fund
this initiative.
Safe and effective BMT nursing requires excellence in assessment,
critical thinking and care of acute and critical complications as well
knowledge in complex BMT treatment plans and skills in commu-
nication with patients, families and an interdisciplinary team.
BMT Nursing Leadership created a structured BMT Internship
Program to support successful recruitment and attainment of
BMT nursing proficiency. The program included didactic educa-
tion, an orientation manual and clinical orientation with a dedicated
preceptor. Clinical orientation was designed according to a BMT
Orientation Pathway, with three tracks individualized and varied
in length according to prior nursing and BMT experience, if any
(see Table 1).
Clinical orientation requires a significant financial investment
and the length of orientation became a concern. Nursing Leader-
ship partnered with Human Resources and the local unemployment
office to investigate opportunities for economic stimulus funds topartially fund the internship program. An ongoing partnership
with the local unemployment office will also create local sourcing
and networking opportunities for viable nursing candidates, as
well as the potential to receive funding through other designed
programs.
Over a 15-month period, 41 nurses were recruited for the BMT
Internship Program and were orientated according to the appropri-
ate track (see Table 1). The program had a 90% success rate with 37
nurses as new members of the BMT inpatient nursing team. Suc-
cesses and challenges of the BMT Internship Program have included
preceptor burnout and organizational issues as well as a change in
nursing culture. Future directions include preceptor support and
continued growth of the individual and collective BMT nursing
expertise.445
USE OF ‘‘RAPID-CYCLE’’ FAILURE MODE AND EFFECTS ANALYSIS (FMEA)
AND SIMULATION TO SAFELY TRANSITION HEMATOPOIETIC STEM CELL
(HSC) PROCESSING SERVICES
Halverson, T.1, Barnard, C.2, Collins, J.1, Duerst, R.1,3 1Children’s Me-
morial Hospital, Chicago, IL; 2NorthwesternMemorial Hospital, Chicago,
IL; 3Northwestern University, Chicago, IL
When Children’s Memorial Hospital (CMH) closed their he-
matopoietic stem cell (HSC) processing laboratory and con-
tracted with the affiliated Northwestern Memorial Hospital for
processing services, it required substantial practice changes and
introduced potential safety risks. The 3-month transition timeline
required the transplant program to make optimal use of time and
resources. ‘‘Rapid-cycle’’ FMEA followed by simulation was used
to evaluate, refine and test the process changes required for this
transition.
Failure mode and effects analysis (FMEA) is a systems-oriented,
prospective approach to process improvement and risk reduction.
FMEA identifies potential process fail-points, assesses their level of
risk, and helps prioritize response with the goal of reducing error oc-
currence and/or mitigating harm. Traditional FMEA is effective but
time-intensive. The ‘‘rapid-cycle’’ adaptation focuses on efficient use
of FMEA meeting time and reduces clinician stakeholder’s involve-
ment to two meetings (see table 1).
To keep the scope manageable, two ‘‘rapid-cycle’’ FMEAs were
conducted. An inter-facility FMEA focused on information and
cell hand-off, and included representation from the hospital, pro-
cessing facility, and courier company. A second, intra-facility
FMEA focused on process changes occurring within the clinical pro-
gram.
The joint FMEA sessions identified 51 potential failure modes.
Failure modes were scored for severity, frequency and detectability;
those identified as high or moderate severity were corrected. The
two items identified as highest risk were (1) incomplete or inaccurate
chain of custody documentation and (2) incomplete information
hand-off between the two institutions. These fail-points were part
of a new process step that required hand-off of cells from CMH to
the outside processing facility via courier. The process was revised
using recommendations developed during the FMEAs, then tested
before the move using simulation.
Sequential use of ‘‘rapid-cycle’’ FMEA followed by simulation
allowed the stem cell transplant program to ‘design out’ potential
Poster Session II S321failures while still adhering to the transition timeline. Clinician as-
sessment of the FMEA process using a 5-point Likert scale found
that participants felt the ‘rapid-cycle’ model was effective and effi-
cient. Post-transition assessment of patient engraftment, graft fail-
ure, and safety event reports provide initial confirmation that
product and patient safety were maintained during this
transition.Traditional vs. ‘‘Rapid-cycle’’ FMEA
Traditional FMEA ‘‘Rapid-cycle’’ FMEA
Purpose A systems-oriented, prospective approach that
identifies potential process fail-points, assesses
their level of risk, and helps prioritizes response
with the goal of reducing error occurrence
and/or mitigating harm
Facilitator
responsibilities
Coordinate
FMEA meetings -
provide expertise
and accountability.
Coordinate FMEA.
Prepare initial process
flows. Begin failpoint
identification.
Calculate risk
priority numbers and
categorize
failure modes
(high, moderate or
low severity).
Group member
(Clinician)
responsibilities
Perform process
mapping. Identify and
score failure modes.
Calculate risk priority
numbers and categorize
failure modes
(high, moderate
or low severity).
Identify corrective
actions.
Focus on failure
mode
identification,
scoring and
correction.
Meeting
requirements
6-12 2
Timeline 4-12 months 2-4 months446
A HEMATOPOIETIC STEM CELL TRANSPLANT QUALITY, CLINICAL,
CELLULAR DASHBOARD: WHAT IS THE EVIDENCE?
Cartwright, F., Andersen, S., Cervone, K.K., Feldman, T., Mendez, S.
New York University Langone Medical Center, New York, NY
Identifying HSCT clinical, quality, cellular indicators with valid
benchmarks is essential to evaluate quality of care and provides di-
rection for program management and growth (strategic planning).
Indicators and benchmarks are selected based on level of evidence
(clinical trial results, survey reports, international and national re-
search data bases), best practices among centers, and institutional
reports. This paper describes the process that an academic institu-
tion used to develop and mainatin an up-to-date HSCT clinical,
quality, cellular dashboard. Using a reveiw of the above literature,
HSCT indicators were evaluated based on the following five cat-
egories: 1) level of priority (relevance), 2) established benchmarks,
3) relationship between process and outcomes, 4) measurable with
numerator and denominator, and 5) ease of data collection. To ex-
plore how variations in institutional and administrative infrastruc-
ture, patient population served, and practice and treatment
patterns influences outcomes and establishment of benchmarks,
a critique of the literature that examined the following indicators
was conducted: microbial contamination of product, blood stream
infections, time to engraftment, ICU admissions, length of stay,
mortality, grade 3 – 4 toxicities. The dashboard guides the Quality
& Performance Improvement Agenda. Opportunities for improve-
ment are identified.447
CRITICAL COMPONENTS OF PATIENT SATISFACTION IN LARGE STEM
CELL TRANSPLANT OUTPATIENT CLINIC
Adornetto-Garcia, D.L., Sorensen, S.H., Stevens, C. UT M.D. Anderson
Cancer Center, Houston, TX
Measuring patient satisfaction in the outpatient clinic of one of
the largest stem cell transplant centers in the country is important
to ongoing improvement of the program. It is also a key activity
of clinical administrative staff in their quest to improve clinic func-
tions. Nursing leaders in the Stem Cell Transplant Outpatient
Clinic identified and measured three targeted patient satisfaction
areas, and based on their findings, implemented changes. The focus
areas included phone communication, continuity of care, and ‘‘wait
times’’. A patient survey process and questions were developed. Sur-
vey questions included items about ease of contacting clinic staff,
how long they were placed on hold, and if staff returned calls. Pa-
tients were asked if they knew their team, were informed of tests,
and received consistent information. They were also surveyed about
length of wait times and time from arrival to seeing their physician,
perceptions of acceptable wait times and whether they were kept in-
formed. Over 100 patients have been surveyed at 6-month intervals
with return rates exceeding 80%. Based on survey findings in these
areas, improvements were made including installation of a new
phone system, voicemail guidelines, a team member sheet, and revi-
sion of education materials. Measurement and evaluation of patient
satisfaction continues to be an important role for the SCT leaders.
Utilizing the survey process, the team is able to review results and
implement action plans for improvement. Staff involvement has
been key to the success of this process. Discussion of results, action
plans, and outcomes are done at staff meetings. Continual follow-up
and evaluation are necessary to assure improvements are sustained.
The findings and improvements made by the SCT leadership team
may be useful to other nurse leaders and staff in their efforts to im-
prove patient satisfaction, a key component to the success of the
SCT journey.TRANSPLANT NURSING: RESEARCH448
COLONIZATION OF TOTAL PARENTERAL NUTRITION ADMINISTRATION
SETS IN IMMUNOCOMPROMISED CHILDREN
Norville, R.1, Lee, D.1, Hyde, A.1, Horvath, B.1, Marilyn, H.2 1Texas
Children’s Hospital, Houston, TX; 2Texas Children’s Hospital, Houston,
TX; 3Texas Children’s Hospital, Houston, TX; 4Texas Children’s Hospital,
Houston, TX; 5Baylor College of Medicine, Houston, TX
Purpose: To determine the incidence of bacterial and yeast colo-
nization in total parenteral nutrition (TPN) fluid administration
sets in immunocompromised children and to explore the inci-
dence of infusate-related bloodstream infection (BSI) in this
group of patients.
Background: Routine replacement of IV administration sets has
been advocated to prevent infectious complications of IV therapy
(deMoissac, 1998). Research studies to date provide no data for in-
fusate-related BSI that compares administration set changes at in-
tervals of 72 hours and 96 hours among patients receiving TPN
(Gillies, 2004).
Sample and Methods: The sample included 14 immunocompro-
mised children who were receiving TPN. Five infusate fluid samples
were collected from each patient for a total of 69 samples. Qualitative
cultures of the TPN fluid were obtained to determine the incidence
of colonization with bacteria and yeast. A 1 ml sample of TPN fluid
was obtained at times 0, 24, 48, 72 and 96 hours after a new TPN ad-
ministration set change. Specimens were obtained from the injection
port immediately above the filter. TPN fluid bags were changed ev-
ery 24 hours.
Results: Twelve bone marrow transplant patients and two oncol-
ogy patients with double lumen central lines participated in the
study. None of the TPN infusate fluid samples were colonized
with bacteria or yeast at any of the data collection time points.
